Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Music
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/92/64/ae/9264aec2-1bdc-aea3-4b83-3226c5aaadb5/mza_14365421335624065445.jpg/600x600bb.jpg
New Retina Radio by Eyetube
Retina Today
217 episodes
3 days ago
New Retina Radio is a place to hear stories about retina that are told nowhere else.
Show more...
Science
Technology
RSS
All content for New Retina Radio by Eyetube is the property of Retina Today and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
New Retina Radio is a place to hear stories about retina that are told nowhere else.
Show more...
Science
Technology
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/92/64/ae/9264aec2-1bdc-aea3-4b83-3226c5aaadb5/mza_14365421335624065445.jpg/600x600bb.jpg
Keeping Patients at the Center of GA Therapy: Dosing Schedules, AREDS Vitamins, and Photobiomodulation
New Retina Radio by Eyetube
15 minutes
1 month ago
Keeping Patients at the Center of GA Therapy: Dosing Schedules, AREDS Vitamins, and Photobiomodulation
Should GA therapy start monthly—or is less-than-monthly treatment enough? In episode 3 of this New Retina Radio miniseries, moderator John Kitchens, MD joins David Eichenbaum, MD; Margaret Chang, MD, MS; and Ferhina Ali, MD, MPH, to share best practices in real-world GA care. The panel debates dosing strategy in light of long-term data, compares safety/efficacy considerations for pegcetacoplan vs avacincaptad pegol (including first-injection inflammation risk), and offers tips for initiating therapy in monocular patients. They also unpack evidence around AREDS vitamins and early experiences with photobiomodulation.This content is editorially independent, supported by Astellas Pharma.
New Retina Radio by Eyetube
New Retina Radio is a place to hear stories about retina that are told nowhere else.